Whalegun
Home

Neurocrine Biosciences NBIX paid Tarplin, Downs & Young $80K for lobbying in Q4 2023 · Health Issues

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q4 2023
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
24/01/20

Up 0.0% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Neurocrine Biosciences's other lobbying reports